Skip to content
HowShorted

Prestige Consumer Healthcare Inc. short interest in 2024

In 2024, Prestige Consumer Healthcare Inc.'s disclosed short interest ran from 3.14% of shares outstanding on 12 Jan 2024 to 5.10% on 31 Dec 2024, a change of +1.96 percentage points. The year's high was 5.11% on 13 Dec 2024 and its low 2.86% on 31 May 2024, averaging 3.97% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.17 days on 13 Sep 2024. Full history: Prestige Consumer Healthcare Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Prestige Consumer Healthcare Inc. in 2024

2024 in figures

Start of year
3.14% (12 Jan 2024)
End of year
5.10% (31 Dec 2024)
Change
+1.96 pp
High
5.11% (13 Dec 2024)
Low
2.86% (31 May 2024)
Average
3.97%
Highest days to cover
10.17 (13 Sep 2024)
SEC filings marked
8

Every report in 2024

Prestige Consumer Healthcare Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20243.14%7.58
31 Jan 20243.47%6.93
15 Feb 20243.47%5.4810-Q filed, results (8-K)
29 Feb 20243.48%9.74
15 Mar 20243.74%6.74
28 Mar 20243.49%7.05
15 Apr 20243.69%9.63
30 Apr 20243.74%8.59
15 May 20243.16%6.06results (8-K), 10-K filed
31 May 20242.86%4.68
14 Jun 20243.76%7.93
28 Jun 20243.99%6.06
15 Jul 20244.15%10.13
31 Jul 20243.95%8.20
15 Aug 20243.65%5.9010-Q filed, results (8-K)
30 Aug 20244.35%10.07
13 Sep 20244.27%10.17
30 Sep 20244.08%7.82
15 Oct 20244.26%9.38
31 Oct 20244.79%10.03
15 Nov 20244.73%6.7010-Q filed, results (8-K)
29 Nov 20244.96%9.27
13 Dec 20245.11%9.58
31 Dec 20245.10%10.03

See also: Prestige Consumer Healthcare Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.